TIVA for ECMO and VAD

Abstract In recent decades, the use of temporary and permanent mechanical assist devices is on rise for patients with end-stage cardiac failure. These support strategies hold inherently different risks in face noncardiac critical illness require multidisciplinary treatment strategies. The main issues all whether extracorporeal membrane oxygenation (ECMO) or ventricular device (VAD), are related to thrombosis, anticoagulation, infection, avoiding hypertension thus intravenous drugs, which requires intense monitoring, circumvent further renal, ischemic neurological injury prevent complication.